Protokinetix Inc

PINK:PKTX USA Biotechnology
Market Cap
$4.58 Million
Market Cap Rank
#34200 Global
#11146 in USA
Share Price
$0.01
Change (1 day)
-17.02%
52-Week Range
$0.01 - $0.01
All Time High
$0.32
About

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufa… Read more

Protokinetix Inc (PKTX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.016x

Based on the latest financial reports, Protokinetix Inc (PKTX) has a cash flow conversion efficiency ratio of -0.016x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.91K) by net assets ($250.43K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Protokinetix Inc - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Protokinetix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Protokinetix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Protokinetix Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Protokinetix Inc (2000–2024)

The table below shows the annual cash flow conversion efficiency of Protokinetix Inc from 2000 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $342.09K $-223.05K -0.652x +24.42%
2023-12-31 $435.86K $-375.99K -0.863x +54.83%
2022-12-31 $421.34K $-804.67K -1.910x +24.25%
2021-12-31 $352.97K $-889.89K -2.521x -21.36%
2020-12-31 $424.22K $-881.31K -2.077x -36.86%
2019-12-31 $560.39K $-850.66K -1.518x +17.67%
2018-12-31 $245.97K $-453.49K -1.844x -13.81%
2017-12-31 $373.54K $-605.11K -1.620x +1.89%
2016-12-31 $496.80K $-820.25K -1.651x -16.27%
2015-12-31 $404.36K $-574.24K -1.420x -365.33%
2014-12-31 $-428.33K $-229.25K 0.535x +214.07%
2013-12-31 $-618.15K $-105.34K 0.170x -80.22%
2011-12-31 $-460.36K $-396.63K 0.862x +251.32%
2010-12-31 $-468.42K $-114.88K 0.245x -72.18%
2009-12-31 $-248.91K $-219.43K 0.882x -72.39%
2008-12-31 $-137.63K $-439.45K 3.193x +29.18%
2007-12-31 $-261.05K $-645.26K 2.472x +229.45%
2006-12-31 $199.25K $-380.46K -1.909x -787.99%
2005-12-31 $2.72 Million $-585.78K -0.215x -60.92%
2004-12-31 $2.91 Million $-389.11K -0.134x -6483.52%
2003-12-31 $2.24 Million $4.68K 0.002x -99.69%
2002-12-31 $-11.56K $-7.89K 0.682x +9776.71%
2000-12-31 $4.96K $-35.00 -0.007x --